Table 5.
Multivariate model of time interval from T0 to first treatment (in days)
| All patients (N = 283) | Patients with NSCLC only (N = 254) | ||||
|---|---|---|---|---|---|
| Characteristic | Beta (days) | p-value | Characteristic | Beta (days) | p-value |
| RIC | −24 (−35 to −12) | <0.01 | RIC | −24 (−37 to −11) | <0.01 |
| Male | −4 (−15 to 8) | 0.53 | Male | −2 (−14 to 11) | 0.77 |
| Age ≥ 75 years | 16 (3 to 30) | 0.02 | Age ≥ 75 years | 14 (0–29) | 0.05 |
| ECOG ≥ 2a | 1 (−16 to 16) | 0.98 | ECOG ≥ 2a | 3 (−14 to 11) | 0.77 |
| NSCLC (vs. SCLC) | 10 (4 to 43) | 0.02 | Stage I-II (vs. Stage III-IV) | 15 (3–28) | 0.02 |
| PET | 17 (2 to 31) | 0.03 | PET | 13 (−4 to 29) | 0.14 |
| EBUS | 2 (−11 to 14) | 0.20 | EBUS | −1 (−14 to 12) | 0.90 |
| Number of non-diagnostic procedures | Number of non-diagnostic procedures | ||||
| 0 | Reference | – | 0 | Reference | – |
| 1 | 20 (6 to 33) | <0.01 | 1 | 18 (5 to 33) | <0.01 |
| ≥1 | 37 (15 to 60) | <0.01 | ≥1 | 38 (14 to 60) | <0.01 |
Patients treated with palliative intent, patients receiving treatment outside the McGill University Health Centre, and patients with time to treatment greater than 1 year were excluded from this analysis. aReference category is patients with ECOG of 0 or 1
NSCLC; SCLC